William John Sibold - President and CEO, Director at Madrigal Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
MDGL on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

William John Sibold - trading volume in the past year for Madrigal Pharmaceuticals, Inc.

Holdings reported by William John Sibold for Madrigal Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 117K $40.5M $344.76 Mar 5, 2025 Direct
Performance Restricted Stock Units 0 $0 $348.94 Feb 27, 2025 Direct Common Stock
Stock Option (Right to Buy) 22K Mar 5, 2025 Direct Common Stock

Transactions reported by William John Sibold for Madrigal Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.